UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 7, 2022

Accession Number:	0001104659-22-032698
Submission Type:	POS AM
CIK: 0001720893 Company Name: BioXcel Therapeutics, Inc. File Number: 333-240118